Showing results (1371-1380 of 2,899) with videos related to

Sort By:
Pageof 290
Blood|July 4, 2001
Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitorsL Teofili, M Martini, A Di Mario, et al.
Journal of Breast Cancer|December 8, 2021
Frailty-Independent Undertreatment Negative Impact on Survival in Older Patients With Breast CancerFernando Osório, António S Barros, Bárbara Peleteiro, et al.
Diabetes Care|February 28, 2014
Cardiovascular risk profile in subjects with prediabetes and new-onset type 2 diabetes identified by HbA(1c) according to American Diabetes Association criteriaAntonino Di Pino, Roberto Scicali, Salvatore Calanna, et al.
Annals of Hematology|July 1, 1991
Treatment of early stage-B chronic lymphocytic leukemia with alpha-2b interferon after chlorambucil reduction of the tumoral massE Montserrat, N Villamor, A Urbano-Ispizua, et al.
Clinical Neuropathology|May 1, 1995
Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markersE Pedrol, J M Grau, J Casademont, et al.
The Journal of Rheumatology|November 1, 1996
Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvementJ M Grau, O Miró, E Pedrol, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|November 1, 1990
[Clinico-morphological changes in ectropion after treatment with polydeoxyribonucleotide (PDRN)]I De Luca Brunori, M Urbano, L Romani, et al.
Psychopharmacology|July 24, 2010
Effects of T-type calcium channel blockers on cocaine-induced hyperlocomotion and thalamocortical GABAergic abnormalities in miceVerónica Bisagno, Mariana Raineri, Viviana Peskin, et al.
Plos One|March 4, 2014
Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (α-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cellsSalvatore Piro, Loriana G Mascali, Francesca Urbano, et al.
Hematological Oncology|November 1, 1992
Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: response to treatment and factors influencing outcomeJ Sierra, A Grañena, F Bosch, et al.
Pageof 290